This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization Europe
5-8 December 2022
Beurs van BerlageAmsterdam, Netherlands

Markus Haindl
Global Head Gene Therapy Technical Operations at Roche

Profile

Markus finished his PhD in 2008 in Molecular Cell Biology at the Max-Planck-Institute of Biochemistry in Munich and subsequently joined McKinsey&Company as a consultant taking over international strategy and operations projects for clients within the Pharma, Biotech and High-Tech industry.

By the end of 2010 Markus joined Roche at the Biotech Centre in Penzberg. Since then he was working as a Groupleader and Department Head in Bioprocess Development and Analytical Development & New Technologies before he took over the Lead for Roche’s efforts towards Technical Development for in vivo Gene Therapies as Global Head Gene Therapy Technical Operations.

Agenda Sessions

  • Keynote Presentation: Addressing Key Challenges Towards Industrialisation of Gene Therapies

    09:15
  • Panel Discussion: Rapid Expansion in the CGT Field – Manufacturing Capacity to Meet Demand

    09:10

Speakers at this event